跳至主要内容
临床试验/IRCT20230222057495N16
IRCT20230222057495N16招募中Unknown

Bioequivalence study of mefenamic acid 250 mg capsule of Jalinous pharmaceutical company compared to mefenamic acid 250 mg sample of Halo pharmaceutical company in the United States of America on healthy volunteers

Jalinous Pharmaceutical Company0 个研究点目标入组 24 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 55 years(—)
性别
All

入选标准

  • Healthy volunteer between 18 and 55 years old.
  • Body mass index less than 30 kg per square meter.
  • All candidates must be non-smokers.

排除标准

  • Blood pressure less than 90 on 60 mm Hg or more than 140 on 90 mm Hg.
  • Consumption of any drug, alcohol or tobacco within 2 weeks before receiving the drug.

研究者

发起方
Jalinous Pharmaceutical Company

相似试验